Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $3.05 Million - $3.4 Million
-30,262 Reduced 68.91%
13,653 $1.42 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $1.22 Million - $1.35 Million
11,123 Added 33.92%
43,915 $4.99 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $2.11 Million - $2.58 Million
23,345 Added 247.12%
32,792 $3.61 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $902,471 - $1.08 Million
9,447 New
9,447 $914,000
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $3.83 Million - $4.43 Million
-39,563 Reduced 37.9%
64,834 $6.27 Million
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $2.16 Million - $2.61 Million
-21,157 Reduced 16.85%
104,397 $11.3 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $1.85 Million - $2.25 Million
-16,199 Reduced 11.43%
125,554 $14.9 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $14.9 Million - $18.3 Million
129,291 Added 1037.48%
141,753 $20 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $1.45 Million - $1.61 Million
12,462 New
12,462 $1.47 Million
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $2.15 Million - $2.53 Million
-19,714 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $1.12 Million - $1.22 Million
-10,625 Reduced 35.02%
19,714 $2.16 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $2.32 Million - $2.82 Million
25,296 Added 501.61%
30,339 $3.3 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $386,142 - $494,214
5,043 New
5,043 $461,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.